A Case of Pancreatic Side Effects Resulting from Sorafenib and Axitinib          Treatment of Stage IV Renal Cell Carcinoma

Yosuke Kitamura; Hidehiko Yoshii; Koshiro Nishimoto; Yusuke Shinchi; Shigeki Tokonabe; Masaya Takao; Yuichiro Daido

doi:10.2302/kjm.2015-0001-CR

CASE REPORT

A Case of Pancreatic Side Effects Resulting from Sorafenib and Axitinib Treatment of Stage IV Renal Cell Carcinoma

Yosuke Kitamura, Hidehiko Yoshii, Koshiro Nishimoto, Yusuke Shinchi, Shigeki Tokonabe, Masaya Takao, Yuichiro Daido

Author information

Keywords: renal cell carcinoma, sorafenib, axitinib, pancreatitis, side effects

JOURNAL FREE ACCESS FULL-TEXT HTML

2015 Volume 64 Issue 4 Pages 62-64

DOI https://doi.org/10.2302/kjm.2015-0001-CR

Details

Abstract

Tyrosine kinase inhibitors such as sorafenib and axitinib were developed to treat malignancies, including stage IV renal cell carcinoma. Recently, we experienced a patient with pancreatic side effects from both sorafenib and axitinib. We report this case and include a discussion of the literature.

Corresponding author

Register with J-STAGE for free!